Enovix Co. (NASDAQ:ENVX - Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $8.65, but opened at $8.26. Enovix shares last traded at $8.20, with a volume of 748,203 shares.
Analyst Ratings Changes
Several equities research analysts have commented on the stock. Benchmark dropped their price objective on shares of Enovix from $25.00 to $15.00 and set a "buy" rating on the stock in a report on Tuesday, April 15th. JPMorgan Chase & Co. dropped their price target on shares of Enovix from $10.00 to $9.00 and set an "overweight" rating on the stock in a research note on Thursday, May 1st. B. Riley cut their price objective on shares of Enovix from $17.00 to $12.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. Craig Hallum lowered their target price on shares of Enovix from $20.00 to $18.00 and set a "buy" rating on the stock in a report on Thursday, February 20th. Finally, TD Securities cut their price target on Enovix from $10.00 to $7.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $17.27.
Get Our Latest Stock Analysis on ENVX
Enovix Price Performance
The stock has a market capitalization of $1.70 billion, a PE ratio of -6.11 and a beta of 2.00. The business's 50-day moving average price is $7.17 and its 200 day moving average price is $8.92. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77.
Institutional Trading of Enovix
A number of large investors have recently modified their holdings of ENVX. Vanguard Group Inc. lifted its position in Enovix by 15.1% during the fourth quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company's stock valued at $171,458,000 after purchasing an additional 2,063,631 shares during the last quarter. Fred Alger Management LLC raised its position in shares of Enovix by 212.4% during the 4th quarter. Fred Alger Management LLC now owns 1,838,914 shares of the company's stock valued at $19,989,000 after buying an additional 1,250,300 shares in the last quarter. Electron Capital Partners LLC lifted its holdings in shares of Enovix by 18.6% during the 1st quarter. Electron Capital Partners LLC now owns 6,712,763 shares of the company's stock worth $49,272,000 after acquiring an additional 1,054,029 shares during the last quarter. CenterBook Partners LP lifted its holdings in shares of Enovix by 71.0% during the 1st quarter. CenterBook Partners LP now owns 1,736,570 shares of the company's stock worth $12,746,000 after acquiring an additional 721,309 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in Enovix by 65.4% in the first quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company's stock valued at $8,351,000 after acquiring an additional 449,934 shares during the last quarter. Institutional investors own 50.92% of the company's stock.
Enovix Company Profile
(
Get Free Report)
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.